Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

JENSEN JESSICA D. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/30/2023 4 JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.
Txns: Granted 136,055 options to buy @ $6.78, valued at $922.5k
04/05/2022 4 JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.
Txns: Granted 13,766 options to buy @ $7.91, valued at $108.9k
03/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.
Txns: Granted 125,553 options to buy @ $6.97, valued at $875.1k
06/30/2021 3 JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 3 on POINT Biopharma Global Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy